Increased apoptosis in patients with major depression: A preliminary study.

Apoptosis is a programmed cell death that can be observed in normal cells. Major depression poses a combination of a depressed and destructive autoimmune reaction. We measured apoptosis in the PBLs of seven patients with major depression and in age- and sex-matched controls. We observed significantly increased apoptosis in the PBLs of depressive patients (p < 0.05). These preliminary results could contribute to an understanding of the interactions of the CNS with the immune system, which could lead to the increased vulnerability of the CNS in depressive disorders. Further studies are needed to establish these results.

[1]  J. Lönnqvist,et al.  [Depression and suicide]. , 1994, Duodecim; laaketieteellinen aikakauskirja.

[2]  F. Zerbi,et al.  PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders. , 1994, Functional neurology.

[3]  S. Cohen,et al.  Depression and immunity: a meta-analytic review. , 1993, Psychological bulletin.

[4]  A. Fattorossi,et al.  The use of Apostain in identifying early apoptosis. , 1997, Journal of immunological methods.

[5]  M. Irwin,et al.  Reduced natural killer cell cytotoxicity in depression but not in schizophrenia , 1991, Biological Psychiatry.

[6]  H. Eckholdt,et al.  Immunity in young adults with major depressive disorder. , 1996, The American journal of psychiatry.

[7]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[8]  N. Nardi,et al.  Evaluation of immune parameters in depressed patients. , 1995, Life sciences.

[9]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  D. Carson,et al.  Apoptosis and disease , 1993, The Lancet.

[11]  M. Campos,et al.  Inhibition of human LAK-cell activity by the anti-depressant trifluoperazine. , 1995, Immunopharmacology.

[12]  A. Guidotti,et al.  Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Zisook,et al.  Bereavement, depression, and immune function , 1994, Psychiatry Research.

[14]  M. Irwin,et al.  Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects , 1992, Psychological Medicine.

[15]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[16]  G. Mason,et al.  Prevalence of antithyroid antibodies in mood disorders , 1997, Depression and anxiety.

[17]  E. Bosmans,et al.  Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. , 1991, Journal of affective disorders.